1. Thrombolysis in Myocardial Infarction (TIMI) Study Group–Brigham and Women’s Hospital, Boston, MA (R.H.M.F., T.A.Z., J.K., S.A.M., D.L.B., C.T.R., M.S.S., S.D.W.).
2. Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.).
3. CPC Clinical Research and Vascular Research Unity, University of Colorado, Denver (M.P.B.).
4. Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel (I.R., O.M., A.C.).
5. Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Ontario, Canada (L.A.L.).
6. Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.).
7. Institute of Ageing and Chronic Disease, University of Liverpool, UK (J.P.H.W.).
8. AstraZeneca Gothenburg, Mölndal, Sweden (I.A.M.G.-N., M.F., A.M.L.).